8-144051397-G-GCGACACCGGCGGTGGGGCGGGGT
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP5
The ENST00000618853.5(OPLAH):c.3795_3796insACCCCGCCCCACCGCCGGTGTCG(p.Pro1266ThrfsTer40) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (no stars).
Frequency
Genomes: not found (cov: 32)
Consequence
OPLAH
ENST00000618853.5 frameshift
ENST00000618853.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.15
Genes affected
OPLAH (HGNC:8149): (5-oxoprolinase, ATP-hydrolysing) The protein encoded by this gene acts as a homodimer, using ATP hydrolysis to catalyze the conversion of 5-oxo-L-proline to L-glutamate. Defects in this gene are a cause of 5-oxoprolinase deficiency (OPLAHD). [provided by RefSeq, Jun 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0186 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-144051397-G-GCGACACCGGCGGTGGGGCGGGGT is Pathogenic according to our data. Variant chr8-144051397-G-GCGACACCGGCGGTGGGGCGGGGT is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3355213.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OPLAH | NM_017570.5 | c.3795_3796insACCCCGCCCCACCGCCGGTGTCG | p.Pro1266ThrfsTer40 | frameshift_variant | 27/27 | ENST00000618853.5 | NP_060040.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OPLAH | ENST00000618853.5 | c.3795_3796insACCCCGCCCCACCGCCGGTGTCG | p.Pro1266ThrfsTer40 | frameshift_variant | 27/27 | 1 | NM_017570.5 | ENSP00000480476 | P1 | |
ENST00000528912.1 | n.1269_1270insACCGGCGGTGGGGCGGGGTCGAC | non_coding_transcript_exon_variant | 5/5 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 35
GnomAD4 exome
Cov.:
35
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
OPLAH-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 27, 2024 | The OPLAH c.3795_3796insACCCCGCCCCACCGCCGGTGTCG variant is predicted to result in a frameshift and premature protein termination (p.Pro1266Thrfs*40). To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. Frameshift variants in OPLAH are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.